Key Segmentation
By Product Type
-
Infectious Disease RDTs
-
Cardiac Marker RDTs
-
Pregnancy & Fertility RDTs
-
Glucose Monitoring RDTs
-
Others
By Technology
-
Lateral Flow Immunoassays (LFIA)
-
Molecular Rapid Tests
-
Agglutination Assays
-
Others
By Application
-
Infectious Disease Testing
-
Cardiology Testing
-
Pregnancy & Fertility Testing
-
Blood Glucose Monitoring
-
Others
By End-User
-
Hospitals & Clinics
-
Diagnostic Laboratories
-
Home Care Settings
-
Others
By Distribution Channel
-
Hospital Pharmacies
-
Retail Pharmacies
-
Online Pharmacies
-
Direct Tenders (Government & NGOs)
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: North America dominated with a 46.84% share in 2025, while Asia-Pacific is the fastest-growing region, expected to expand at a CAGR of 9.74% during 2026–2035.
Ans: Infectious Disease RDTs dominated with a 52.75% share in 2025, while Infectious Disease RDTs s are also projected to grow at the fastest CAGR of 8.12% during 2026–2035.
Ans: Growth is driven by rising prevalence of infectious diseases, increasing demand for point-of-care testing, expanding adoption of home-based diagnostic kits, and advancements in rapid diagnostic technologies.
Ans: The market is valued at USD 32.88 Billion in 2025 and is projected to reach USD 67.83 Billion by 2035.
Ans: The Rapid diagnostic tests Market is projected to grow at a CAGR of 7.62% during 2026–2035.